SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-08-090339
Filing Date
2008-04-25
Accepted
2008-04-25 10:04:36
Documents
5
Effectiveness Date
2008-04-25

Document Format Files

Seq Description Document Type Size
1 ADDITIONAL MATERIALS ddefa14a.htm DEFA14A 31406
2 GRAPHIC g51422img_001.jpg GRAPHIC 161046
3 GRAPHIC g51422img_002.jpg GRAPHIC 80061
4 GRAPHIC g51422img_003.jpg GRAPHIC 62440
5 GRAPHIC g51422img_004.jpg GRAPHIC 61404
  Complete submission text file 0001193125-08-090339.txt   536238
Mailing Address 4222 EMPEROR BLVD STE 200 DURHAM NC 27703-8466
Business Address 4222 EMPEROR BLVD STE 200 DURHAM NC 27703-8466 9199419777
INSPIRE PHARMACEUTICALS INC (Filer) CIK: 0001040416 (see all company filings)

IRS No.: 043209022 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-31577 | Film No.: 08776144
SIC: 2834 Pharmaceutical Preparations